SLC5A2 and atrial fibrillation: The enrolment period was before the guideline-recommended implementation of the holistic and integrated management of AF, and before the widespread use of some classes of medications (i.e. sodium-glucose cotransporter 2 inhibitors, angiotensin receptor/neprilysin inhibitors).